Valenta Participated in the 18th International Slavic-Baltic Forum

Valenta Participated in the 18th International Slavic-Baltic Forum


In May 2016, the 18th International Slavic-Baltic Scientific Forum “St.-Petersburg - Gastro-2016” was held in St.-Petersburg. The Forum brought together leading Russian and foreign experts-gastroenterologists. N.L.Denisov, MD, Professor at the Faculty №2 of Professional Advancement for Doctors, S.M. Kirov MMA, Member of the Presidium of the Russian Gastroenterology Association; K.A.Shemerovsky, MD, Chief Researcher at the Laboratory of Digestion Physiology at the Department of Visceral Systems Physiology at the Institute of Experimental Medicine, NWB RAMS; and L.I.Butorova, CM, Associate Professor at CDC of the Sechenov FMSMU, presented their reports at two plenary sessions organized with the support of Valenta.

Statistics in the field of gastroenterological diseases is unfavorable. These diseases occupy the 3rd - 4th places in the structure of all diseases in the Russian Federation. About 37% of people visiting therapists suffer from digestive system disorders1. In this connection, participants of the Forum emphasized the urgency of the problem of gastroenterological disorders, and detailed the issues of epidemiology, diagnostics and pharmacotherapeutical treatment of such common diseases as functional dyspepsia (FD) and irritable bowel syndrome (IBS). In the reports, they also covered the principles of treatment and opportunities of optimization of therapy for patients with chronic constipation, and considered principal causes, classification and methods of treatment of chronic flatulence.

Within the plenary session, N.L.Denisov presented the results of Trimedat® trials for treatment of IBS in a daily dose of 600 mg over 1 month, and then in a half-dose over 3 months to prevent the relapse. The results confirmed that the medicine, in comparison with placebo, removed the painful syndrome and constipation and reduced displays of flatulence. The supporting therapy with application of the medicine, in a dose of 100 mg 3 times a day, proved to promote further decrease of flatulence displays while preventing constipations and pains.

L.I.Butorova described the features of alimentary flatulence connected with use of food which digestion process causes increased gas production, and spoke about new BAA Orliks® (source of alpha-galactosidase digestive enzyme, 5 mg per tablet). Within the small intestine, it breaks oligosaccharides contained in vegetables, fruits, beans and wholegrain cereals down to monosaccharides, thus preventing excessive gas production in the large intestine.

  • 1 Data of the RF Ministry of Health, 2014.